naproxen has been researched along with Delayed Effects, Prenatal Exposure in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akgun, H; Gurgoze, M; Koklu, E; Ozturk, MA; Poyrazoglu, MH | 1 |
Burdan, F; Przybylski, P; Sykut, J | 1 |
Fraser, W; Garner, P; Krewski, D; Nimrod, C; Olatunbosun, O; Walker, MC; Wen, SW; Yang, Q; Yang, T | 1 |
Alano, MA; Konduri, GG; Ngougmna, E; Ostrea, EM | 1 |
4 other study(ies) available for naproxen and Delayed Effects, Prenatal Exposure
Article | Year |
---|---|
Renal tubular dysgenesis with atypical histology and in-utero exposure to naproxen sodium.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anuria; Fatal Outcome; Female; Humans; Infant, Newborn; Kidney Tubules, Proximal; Maternal-Fetal Exchange; Naproxen; Pregnancy; Prenatal Exposure Delayed Effects | 2006 |
[Developmental toxicity of naproxen].
Topics: Abnormalities, Drug-Induced; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Ductus Arteriosus; Dysmenorrhea; Female; Heart Septal Defects, Ventricular; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Mice; Naproxen; Osteoarthritis; Persistent Fetal Circulation Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Rabbits; Rats; Species Specificity | 2007 |
Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population.
Topics: Adult; Albuterol; Contraceptives, Oral; Cross-Sectional Studies; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Female; Gestational Age; Humans; Ibuprofen; Infant, Newborn; Naproxen; Population Surveillance; Pregnancy; Prenatal Exposure Delayed Effects; Saskatchewan; Trimethoprim, Sulfamethoxazole Drug Combination; United States; United States Food and Drug Administration | 2008 |
Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bronchodilator Agents; Extracorporeal Membrane Oxygenation; Female; Gas Chromatography-Mass Spectrometry; Humans; Ibuprofen; Infant, Newborn; Logistic Models; Meconium; Naproxen; Nitric Oxide; Persistent Fetal Circulation Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Risk | 2001 |